These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36694432)

  • 1. Stimulation of platelet P2Y
    Arkless KL; Pan D; Shankar-Hari M; Amison RT; Page CP; Rahman KM; Pitchford SC
    Br J Pharmacol; 2024 Feb; 181(4):564-579. PubMed ID: 36694432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring bias in platelet P2Y
    Pan D; Ladds G; Rahman KM; Pitchford SC
    Br J Pharmacol; 2024 Feb; 181(4):580-592. PubMed ID: 37442808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse signalling of the platelet P2Y
    Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
    Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
    Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
    Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of P2Y
    Paul DS; Blatt TN; Schug WJ; Clark EG; Kawano T; Mackman N; Murcia S; Poe KO; Mwiza JMN; Harden TK; Bergmeier W; Nicholas RA
    J Thromb Haemost; 2023 Jul; 21(7):1891-1902. PubMed ID: 36958516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y
    Amison RT; Arnold S; O'Shaughnessy BG; Cleary SJ; Ofoedu J; Idzko M; Page CP; Pitchford SC
    Pulm Pharmacol Ther; 2017 Aug; 45():62-68. PubMed ID: 28487256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.
    Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A
    PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
    Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.
    Durnin L; Hwang SJ; Kurahashi M; Drumm BT; Ward SM; Sasse KC; Sanders KM; Mutafova-Yambolieva VN
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15821-6. PubMed ID: 25341729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
    Jones S; Evans RJ; Mahaut-Smith MP
    Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
    Kim KA; Song WG; Lee HM; Joo HJ; Park JY
    Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
    Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
    Jin J; Daniel JL; Kunapuli SP
    J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
    Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
    J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets.
    Koessler J; Hermann S; Weber K; Koessler A; Kuhn S; Boeck M; Kobsar A
    PLoS One; 2016; 11(1):e0147370. PubMed ID: 26808867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ADP receptors in platelet function.
    Murugappa S; Kunapuli SP
    Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
    Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
    Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.
    Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.